Trius Therapeutics, Inc. (NASDAQ:TSRX) Investor Lawsuit Against Takeover Filed
An investor, who currently holds shares of Trius Therapeutics, Inc. (NASDAQ:TSRX), filed a lawsuit in effort to halt the proposed takeover of Trius Therapeutics, Inc. by Cubist Pharmaceuticals, Inc.
View full press release